Corporate carve-out specialist Japan Industrial Partners (JIP) has closed the offshore portion of its latest fund and is poised to raise JPY102.3 billion ($996 million) in total once commitments from onshore investors are finalized. There will also be a JPY46.2 billion co-investment vehicle.
The offshore portion of the main fund is JPY76.3 billion, with a further JPY26 billion to be raised from onshore investors. That tranche is scheduled to close in June, according to sources familiar with...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.